ADTX
ADTX
NASDAQ · Biotechnology

Aditxt Inc

$1.30
+0.05 (+4.00%)
As of Mar 22, 11:06 PM ET ·
Financial Highlights (FY 2026)
Revenue
578.23M
Net Income
-148,652,679,361
Gross Margin
-368.3%
Profit Margin
-25,708.3%
Rev Growth
+6.8%
D/E Ratio
0.65
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin -368.3% -368.3% 36.5% 36.5%
Operating Margin -20,951.1% -18,856.0% -8.5% -8.3%
Profit Margin -25,708.3% -24,422.8% -10.9% -10.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 578.23M 541.41M 180.5K 146.0K
Gross Profit -2,129,618,736 -1,994,025,033 65.8K 53.3K
Operating Income -121,145,353,829 -102,088,781,316 -15,427 -12,144
Net Income -148,652,679,361 -125,269,111,821 -19,611 -15,138
Gross Margin -368.3% -368.3% 36.5% 36.5%
Operating Margin -20,951.1% -18,856.0% -8.5% -8.3%
Profit Margin -25,708.3% -24,422.8% -10.9% -10.4%
Rev Growth +6.8% +6.8% +10.1% +10.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 128.0K 128.0K 133.1K 136.4K
Total Equity 195.7K 195.7K 143.0K 117.9K
D/E Ratio 0.65 0.65 0.93 1.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -118,496,025,710 -105,403,768,187 -25,362 -18,933
Free Cash Flow -13,693 -9,143